FDC
Ticker > Company >

FDC share price

FDC Ltd.

NSE: FDC BSE: 531599 SECTOR: Pharmaceuticals & Drugs  1.11 L   340   51

458.75
-7.00 (-1.50%)
BSE: 09 Sep 04:01 PM

Price Summary

Today's High

₹ 469.8

Today's Low

₹ 455.8

52 Week High

₹ 659

52 Week Low

₹ 358.95

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 7468.91 Cr.

Enterprise Value

₹ 7427.94 Cr.

No. of Shares

16.28 Cr.

P/E

26.6

P/B

3.1

Face Value

₹ 1

Div. Yield

1.09 %

Book Value (TTM)

₹  147.99

CASH

₹ 40.97 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

69.66 %

EPS (TTM)

₹  17.25

Sales Growth

8.03%

ROE

12.48 %

ROCE

16.98%

Profit Growth

-10.92 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of FDC Ltd.

Electral Enerzal Vitcofol Pyrimon Zocon Zoxan Zathrin Zipod Zefu Cotaryl and Mycoderm

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year8.03%
3 Year10.87%
5 Year9.23%

Profit Growth

1 Year-10.92%
3 Year7.6%
5 Year2.09%

ROE%

1 Year12.48%
3 Year12.59%
5 Year13.56%

ROCE %

1 Year16.98%
3 Year16.8%
5 Year17.9%

Debt/Equity

0

Price to Cash Flow

24.07

Interest Cover Ratio

82.9233

CFO/PAT (5 Yr. Avg.)

0.824219993724731

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 69.66 0.00
Mar 2025 69.66 0.00
Dec 2024 69.66 0.00
Sep 2024 69.66 0.00
Jun 2024 69.66 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 0.0321 Cr.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 82.9233.
  • The company has an efficient Cash Conversion Cycle of -14.4857 days.
  • Company has a healthy liquidity position with current ratio of 2.3052.
  • The company has a high promoter holding of 69.66%.

 Limitations

  • The company has shown a poor profit growth of 7.60147111099025% for the Past 3 years.
  • The company has shown a poor revenue growth of 10.8702160842412% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 624.14 505.1 458.86 482 642.28
Total Expenditure 482.45 432.7 412.92 429.18 500.95
Operating Profit 141.69 72.4 45.95 52.83 141.34
Other Income 28.15 34.68 18.65 31.43 35.59
Interest 1.29 1.07 0.94 1.18 1.16
Depreciation 11 13.76 13.32 15.53 14.88
Exceptional Items 0 0 0 0 0
Profit Before Tax 157.56 92.25 50.32 67.54 160.88
Tax 42.57 18.28 13.87 19.33 38.69
Profit After Tax 114.99 73.97 36.45 48.22 122.19
Adjusted EPS (Rs) 7.06 4.54 2.24 2.96 7.51

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 1325.45 1518.97 1777.03 1916.19 2070.11
Total Expenditure 1001.12 1272.12 1523.84 1577.73 1749.86
Operating Profit 324.33 246.85 253.19 338.46 320.25
Other Income 97.15 78.73 55.29 103.22 105.52
Interest 3.4 3.05 4.04 4 4.49
Depreciation 37.62 37.08 38.76 39.73 53.61
Exceptional Items 0 0 0 0 0
Profit Before Tax 380.45 285.45 265.69 397.95 367.67
Tax 85.96 65.82 64.72 90.78 94.05
Net Profit 294.49 219.64 200.97 307.16 273.63
Adjusted EPS (Rs.) 17.45 13.01 12.11 18.87 16.81

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 16.88 16.88 16.59 16.28 16.28
Total Reserves 1705.28 1931.8 1964.15 2080.92 2270.91
Borrowings 0.21 0.11 0.03 0 0
Other N/C liabilities 299.36 384.32 462.62 597.62 808.92
Current liabilities 620.07 688.6 728.67 612.23 543.7
Total Liabilities 2641.8 3021.71 3172.07 3307.04 3639.82
Assets
Net Block 685.02 700.97 694.93 676.39 847.5
Capital WIP 19.21 104.24 197.73 260.88 136.09
Intangible WIP 0 0.11 0.11 0 0.08
Investments 265.58 384.95 348.71 399.7 565.07
Loans & Advances 328.73 424.04 487.39 609.5 833.19
Other N/C Assets 5.03 0.84 3.3 5.45 4.56
Current Assets 1338.24 1406.56 1439.89 1355.13 1253.32
Total Assets 2641.8 3021.71 3172.07 3307.04 3639.82
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 380.45 285.45 265.69 397.95 367.67
Adjustment -40.75 -23.59 1 -52.32 -39.91
Changes in Assets & Liabilities -36.05 -21.17 -25.11 -21.91 85.4
Tax Paid -93.81 -78.31 -76.86 -102.9 -102.82
Operating Cash Flow 209.84 162.38 164.72 220.81 310.34
Investing Cash Flow -84.15 -147.27 3.73 -17.75 -199.33
Financing Cash Flow -126.49 -9.7 -179.83 -202.03 -92.1
Net Cash Flow -0.8 5.41 -11.38 1.02 18.9

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 69.66 69.66 69.66 69.66 69.66
aditi c bhanot 0.68 0.68 0.68 0.68 0.68
ameya ashok chandavarkar 6.10 6.10 6.10 6.10 6.10
leo advisors pvt ltd (trs... - - - - 9.17
nandan mohan chandavarkar... 3.10 24.92 3.10 3.10 3.10
nandan mohan chandavarkar... - - - - 11.01
nandan mohan chandavarkar... - - 10.81 - 10.81
nomita r chandavarkar 22.67 22.67 22.67 22.67 22.67
virgo advisors pvt ltd (t... - - - - 6.12
leo advisors pvt ltd 9.17 9.17 9.17 9.17 -
nandan mohan chandavarkar... - - 11.01 11.01 -
nandan mohan chandavarkar... - - - 10.81 -
virgo advisors pvt ltd 6.12 6.12 6.12 6.12 -
nandan mohan chandavarkar... 11.01 - - - -
nandan mohan chandavarkar... 10.81 - - - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 30.34 30.34 30.34 30.34 30.34
icici prudential smallcap... - 2.51 2.57 2.87 3.59
investor education and pr... 0.22 0.22 0.22 0.30 0.30
llp 0.06 0.08 0.07 0.06 0.08
nippon life india trustee... 2.64 2.61 2.61 2.61 2.63
icici prudential smallcap... 3.17 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
Research HDFC Securities
Research HDFC Securities
Research Rudra Shares and Stock Brokers Ltd
Research ICICI Securities Limited

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY22
Concall Q4FY22
Concall Q2FY24
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY22
Presentation Q2FY24

Company News

FDC - Quaterly Results 7 Aug, 2:05 PM FDC - Quaterly Results 7 Aug, 2:05 PM FDC - Quaterly Results 7 Aug, 2:05 PM FDC informs about board meeting 1 Aug, 12:49 PM FDC informs about press release 29 May, 12:43 PM FDC - Quaterly Results 28 May, 5:05 PM FDC - Quaterly Results 28 May, 5:05 PM FDC - Quaterly Results 28 May, 5:05 PM FDC informs about board meeting 22 May, 2:52 PM FDC recalling 60,428 bottles of Timolol Maleate Ophthalmic Solution in US market 12 May, 12:44 PM FDC informs about compliances certificate 14 Apr, 2:48 PM FDC - Quaterly Results 12 Feb, 3:17 PM FDC - Quaterly Results 12 Feb, 3:17 PM FDC - Quaterly Results 12 Feb, 3:17 PM FDC informs about board meeting 7 Feb, 2:25 PM FDC informs about certificate 10 Jan, 5:23 PM FDC informs about compliances-certificate 10 Jan, 5:22 PM FDC informs about issuance of duplicate share certificates 26 Dec, 5:06 PM FDC informs about closure of trading window 26 Dec, 3:28 PM FDC gets final nod for Cefixime 400 mg Tablets 18 Dec, 5:08 PM FDC informs about disclosure 18 Dec, 4:56 PM FDC informs about loss of share certificate 13 Dec, 5:14 PM FDC submits intimation of company's new correspondence address 12 Dec, 1:18 PM FDC recalling 1,55,232 bottles of Timolol Maleate ophthalmic solution in US market 18 Nov, 11:00 AM FDC - Quaterly Results 6 Nov, 4:21 PM FDC - Quaterly Results 6 Nov, 4:21 PM FDC - Quaterly Results 6 Nov, 4:21 PM FDC recalling bottles of Timolol Maleate Ophthalmic Solution 27 Aug, 2:42 PM FDC informs about updates 23 Aug, 5:31 PM USFDA completes audit at FDC’s Baddi manufacturing facility 23 Aug, 4:30 PM FDC informs about disclosure 8 Aug, 3:28 PM FDC - Quaterly Results 7 Aug, 3:03 PM FDC - Quaterly Results 7 Aug, 3:03 PM FDC - Quaterly Results 7 Aug, 3:03 PM FDC informs about board meeting 26 Jul, 5:22 PM FDC informs about certificate 12 Jul, 2:27 PM FDC informs about closure of trading window 25 Jun, 2:42 PM FDC informs about details of loss of certificate 15 Jun, 1:27 PM FDC informs about press release 30 May, 2:59 PM FDC - Quaterly Results 29 May, 5:44 PM FDC - Quaterly Results 29 May, 5:44 PM FDC - Quaterly Results 29 May, 5:44 PM FDC informs about compliance certificate 20 Apr, 12:54 PM FDC informs about disclosure 3 Apr, 2:25 PM FDC - Quaterly Results 7 Feb, 2:44 PM FDC - Quaterly Results 7 Feb, 2:44 PM FDC - Quaterly Results 7 Feb, 2:44 PM FDC informs about certificate 9 Jan, 2:55 PM FDC informs about details of loss of certificate 16 Dec, 2:45 PM FDC submits investor presentation 16 Nov, 12:43 PM

FDC Stock Price Analysis and Quick Research Report. Is FDC an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse FDC. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). FDC has a PE ratio of 26.5237380208364 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. FDC has ROA of 7.8777% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. FDC has a Current ratio of 2.3052.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. FDC has a ROE of 12.4818%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. FDC has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: FDC has reported revenue growth of 8.0329% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of FDC for the current financial year is 15.4700332866064%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for FDC is Rs 5 and the yield is 1.0899%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of FDC is Rs 17.2487. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of FDC in Ticker for free. Also, one can get the intrinsic value of FDC by using Valuation Calculators, which are available with a Finology ONE subscription. 

FDC FAQs

Q1. What is FDC share price today?
Ans: The current share price of FDC is Rs 457.5.

Q2. What is the market capitalisation of FDC?
Ans: FDC has a market capitalisation of Rs 7448.561343 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of FDC?
Ans: The PE ratio of FDC is 26.5237380208364 and the P/B ratio of FDC is 3.0914856767921, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of FDC share?
Ans: The 52-week high share price of FDC is Rs 658.85, and the 52-week low share price of FDC is Rs 366.25.

Q5. Does FDC pay dividends?
Ans: Currently, FDC pays dividends. Dividend yield of FDC is around 1.0899%.

Q6. What are the face value and book value of FDC shares?
Ans: The face value of FDC shares is Rs 1, while the book value per share of FDC is around Rs 147.9871. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of FDC?
Ans: FDC has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of FDC?
Ans: The ROE of FDC is 12.4818% and ROCE of FDC is 16.9764%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is FDC a good buy for the long term?
Ans: The FDC long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is FDC undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the FDC appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check FDC’s financials?
Ans: You can review FDC’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about FDC

FDC Ltd. Financials: Check Share price, Balance Sheet, Annual report and Quarterly Results for company analysis

FDC Ltd. is a renowned pharmaceutical company in India, known for its exceptional portfolio of healthcare products. This detailed stock analysis aims to provide long-term stock investors with valuable insights into various aspects of the company's financial performance, without including numbers or financial data points.

FDC Ltd. Share Price Assessment

The share price of FDC Ltd. has demonstrated a consistent track record with moderate fluctuations over time. As of the latest available information, the stock is trading at a competitive price. Investors looking for a well-performing pharmaceutical company can utilize our pre-built screening tools to monitor the share price and make informed investment decisions. A stock's share price is determined by a range of factors such as market sentiment, financial performance, and general economic conditions.

FDC Ltd. Balance Sheet Evaluation

FDC Ltd.'s balance sheet reveals a strong financial position with stable growth in assets such as inventory, property, and receivables. The company's liabilities primarily consist of borrowings and payables. The balance sheet evaluation can help investors assess the company's liquidity and financial stability. Our premium feature tools, including DCF Analysis, BVPS Analysis, Earnings Multiple Approach, and DuPont Analysis, provide an in-depth analysis of the company's performance.

FDC Ltd. Annual Report Insights

Investors can gain a deep understanding of FDC Ltd.'s operations, financial performance, and future prospects by reviewing the company's annual reports, which are available for download on our website. These reports provide essential information about the company's management policies, business strategies, and financial targets.

FDC Ltd. Dividend Analysis

FDC Ltd. has a consistent dividend payment record, which can be of interest to long-term stock investors. Our pre-built screening tools allow investors to track the company's dividend history and payout ratios. Dividend analysis aids investors in understanding the company's dividend policy and the potential returns associated with holding FDC Ltd. stock.

FDC Ltd. Quarterly Result Review

The quarterly results of FDC Ltd. offer relevant information regarding the company's revenue, net income, and EPS (earnings per share). Access to the latest quarterly results provides investors with insights into the company's financial performance on a more frequent basis. Utilize our website to download these results and compare them with previous quarters. Our premium feature tools can facilitate a more detailed analysis of FDC Ltd.'s quarterly performance.

FDC Ltd. Stock Price Chart Analysis

The stock price chart for FDC Ltd. displays a steady growth pattern with occasional fluctuations. Investors can use the chart to evaluate the stock's historical performance and assess its potential for long-term growth. Analysis of the stock price chart aids investors in understanding market trends and making informed investment decisions. Our website provides pre-built screening tools to help investors analyze stock price and performance.

FDC Ltd. News and Concall Updates

Stay up to date with the latest news and updates on FDC Ltd. through our website, which provides information on earnings announcements, management changes, and industry developments. Additionally, we offer access to transcripts of company concalls, enabling investors to gain further insights into FDC Ltd.'s operations and strategies.

FDC Ltd. Investor Presentations Examination

Investor presentations offered by FDC Ltd. showcase the company's business models, growth plans, and financial targets. By reviewing these presentations, investors can gain a better understanding of the company's vision and evaluate its potential for long-term success. Our website provides access to these investors presentations for thorough analysis.

FDC Ltd. Promoters and Shareholders Insight

FDC Ltd. boasts a dedicated group of promoters with extensive experience in the pharmaceutical industry. The company's shareholders include a blend of retail investors, institutional investors, and mutual funds. Learn more about FDC Ltd.'s promoter group and major shareholders through our website.

FDC Limited ROCE

The Return on Capital Employed (ROCE) is an important ratio that determines the profitability and efficiency of a company's capital investments. FDC Limited's ROCE can be found in the financials table or ratio section on this page. ROCE indicates how well the company uses its capital to generate profits and is expressed as a percentage. A higher ROCE suggests better capital allocation and profitability for FDC Limited.

FDC Limited EBITDA

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. This financial metric provides a measure of a company's operating performance without the impact of financial and accounting decisions. FDC Limited's EBITDA can be accessed in the financials table or ratio section. EBITDA is useful for comparing companies' profitability and is often used as an indicator of cash flow generation.

FDC Limited DPS

Dividends Per Share (DPS) is a financial ratio that represents the portion of a company's earnings distributed to its shareholders in the form of dividends. FDC Limited's DPS information is available in the financials table or ratio section. DPS is useful for investors looking for income from their investments, as it indicates the dividend payout per share and highlights the company's dividend policy and financial stability.

FDC Limited EPS

Earnings Per Share (EPS) is a common financial ratio that represents the portion of a company's profit allocated to each outstanding share of common stock. FDC Limited's EPS can be found in the financials table or ratio section on this page. EPS is a crucial metric for investors as it provides an indicator of a company's profitability and allows for comparison across different companies in the industry.

Please note that the specific values and trends for all these ratios can be found in the financials table or ratio section provided on this page. 

FDC Balance Sheet Analysis

FDC Share Capital Trends

Between March 2020 and March 2024, FDC's share capital shows a slight decrease from Rs 17.10 Cr. to Rs 16.28 Cr. This reduction suggests a conservative approach towards capital structure, likely revolving around buybacks or cancellation of shares.

FDC Reserves Growth

FDC's total reserves have witnessed a consistent upward trajectory, climbing from Rs 1,524.72 Cr. in March 2020 to Rs 2,080.92 Cr. by March 2024. This indicates a robust accumulation of retained earnings, possibly stemming from sustained profitability.

FDC Debt Analysis

FDC's approach to managing borrowings is notable, with a sharp reduction from Rs 0.34 Cr. in March 2020 to a complete payoff by March 2024. This positions the company advantageously from a financial risk perspective.

FDC Asset Growth

Over the examined period, FDC's total assets expanded from Rs 2,418.80 Cr. to Rs 3,307.04 Cr., driven notably by increases in Capital WIP and Loans & Advances. Significant investments in capital work-in-progress might reflect ongoing expansions or upgrades in facilities.

The analysis provided is based on a standalone review of FDC's balance sheet.

Such balance sheet resilience and strategic asset management can be crucial metrics for investors in sectors like pharmaceuticals, a highly competitive field on indices like NSE and BSE.

Read More
X